Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
Cancer
|
April 22, 2009
Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment
B Ashleigh Guadagnolo, Gunar K Zagars, A Kevin Raymond, et al.
Skeletal Radiology
|
April 19, 2011
Intraneural parachordoma of the arm with regional metastases
Amalia M De Comas, Michael T Deavers, A Kevin Raymond, et al.
Clinical Orthopaedics and Related Research
|
November 13, 2003
Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis
Catherine G Ambrose, Gloria R Gogola, Terry A Clyburn, et al.
Cancer
|
June 12, 2009
Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus
Giri R Gupta, Alan W Yasko, Valerae O Lewis, et al.
Cancer
|
September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate
Lucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Cancer
|
March 7, 2006
Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate
Dejka M Steinert, Mauricio Oyarzo, Xuemei Wang, et al.
Journal of Pediatric Surgery
|
January 18, 2006
Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma
Matthew T Harting, Martin L Blakely, Norman Jaffe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate
John C McAuliffe, Alexander J F Lazar, Dan Yang, et al.
Skeletal Radiology
|
September 18, 2009
Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis
Colleen M Costelloe, A Kevin Raymond, Nancy E Fitzgerald, et al.
Cancer
|
June 29, 2004
A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis
Shreyaskumar R Patel, Nicholas Papadopolous, A Kevin Raymond, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
Cancer
|
April 22, 2009
Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment
B Ashleigh Guadagnolo, Gunar K Zagars, A Kevin Raymond, et al.
Skeletal Radiology
|
April 19, 2011
Intraneural parachordoma of the arm with regional metastases
Amalia M De Comas, Michael T Deavers, A Kevin Raymond, et al.
Clinical Orthopaedics and Related Research
|
November 13, 2003
Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis
Catherine G Ambrose, Gloria R Gogola, Terry A Clyburn, et al.
Cancer
|
June 12, 2009
Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus
Giri R Gupta, Alan W Yasko, Valerae O Lewis, et al.
Cancer
|
September 26, 2006
Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate
Lucian R Chirieac, Jonathan C Trent, Dejka M Steinert, et al.
Cancer
|
March 7, 2006
Expression of Bcl-2 in gastrointestinal stromal tumors: correlation with progression-free survival in 81 patients treated with imatinib mesylate
Dejka M Steinert, Mauricio Oyarzo, Xuemei Wang, et al.
Journal of Pediatric Surgery
|
January 18, 2006
Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma
Matthew T Harting, Martin L Blakely, Norman Jaffe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 2007
Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate
John C McAuliffe, Alexander J F Lazar, Dan Yang, et al.
Skeletal Radiology
|
September 18, 2009
Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis
Colleen M Costelloe, A Kevin Raymond, Nancy E Fitzgerald, et al.
Cancer
|
June 29, 2004
A phase II study of cisplatin, doxorubicin, and ifosfamide with peripheral blood stem cell support in patients with skeletal osteosarcoma and variant bone tumors with a poor prognosis
Shreyaskumar R Patel, Nicholas Papadopolous, A Kevin Raymond, et al.
Page
of 3